These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8850464)
21. Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma. Ris HB; Altermatt HJ; Nachbur B; Stewart JC; Wang Q; Lim CK; Bonnett R; Althaus U Int J Cancer; 1993 Jan; 53(1):141-6. PubMed ID: 8416199 [TBL] [Abstract][Full Text] [Related]
22. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma. Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216 [TBL] [Abstract][Full Text] [Related]
23. Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves. Kübler AC; Stenzel W; Rühling M; Meul B; Fischer JH Lasers Surg Med; 2003; 33(4):247-55. PubMed ID: 14571449 [TBL] [Abstract][Full Text] [Related]
24. mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells. Reidy K; Campanile C; Muff R; Born W; Fuchs B Photochem Photobiol; 2012; 88(3):721-7. PubMed ID: 22268498 [TBL] [Abstract][Full Text] [Related]
25. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Yom SS; Busch TM; Friedberg JS; Wileyto EP; Smith D; Glatstein E; Hahn SM Photochem Photobiol; 2003 Jul; 78(1):75-81. PubMed ID: 12929752 [TBL] [Abstract][Full Text] [Related]
26. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats. Tsutsui H; MacRobert AJ; Curnow A; Rogowska A; Buonaccorsi G; Kato H; Bown SG Lasers Med Sci; 2002; 17(2):101-9. PubMed ID: 12111593 [TBL] [Abstract][Full Text] [Related]
27. Endobronchial photodynamic therapy: comparison of mTHPC and polyethylene glycol-derived mTHPC on human tumor xenografts and tumor-free bronchi of minipigs. Ris HB; Im Hof V; Stewart CM; Mettler D; Altermatt HJ Lasers Surg Med; 1998; 23(1):25-32. PubMed ID: 9694147 [TBL] [Abstract][Full Text] [Related]
28. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Friedberg JS; Mick R; Stevenson J; Metz J; Zhu T; Buyske J; Sterman DH; Pass HI; Glatstein E; Hahn SM Ann Thorac Surg; 2003 Mar; 75(3):952-9. PubMed ID: 12645723 [TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia. Campbell SM; Gould DJ; Salter L; Clifford T; Curnow A Br J Dermatol; 2004 Nov; 151(5):1076-80. PubMed ID: 15541088 [TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy as novel nephron sparing treatment option for small renal masses. Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991 [TBL] [Abstract][Full Text] [Related]
31. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Mang TS; Allison R; Hewson G; Snider W; Moskowitz R Cancer J Sci Am; 1998; 4(6):378-84. PubMed ID: 9853137 [TBL] [Abstract][Full Text] [Related]
32. Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Ell C; Gossner L; May A; Schneider HT; Hahn EG; Stolte M; Sroka R Gut; 1998 Sep; 43(3):345-9. PubMed ID: 9863479 [TBL] [Abstract][Full Text] [Related]
33. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas. Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244 [TBL] [Abstract][Full Text] [Related]
35. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines. Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263 [TBL] [Abstract][Full Text] [Related]
36. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC. van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026 [TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC). Mikvy P; Messman H; MacRobert AJ; Pauer M; Sams VR; Davies CL; Stewart JC; Bown SG Br J Cancer; 1997; 76(6):713-8. PubMed ID: 9310235 [TBL] [Abstract][Full Text] [Related]
38. The use of photodynamic therapy as adjuvant therapy to surgery in recurrent malignant tumors of the paranasal sinuses. Caesar L; van Doeveren TE; Tan IB; Dilci A; van Veen RL; Karakullukcu B Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):414-21. PubMed ID: 26072296 [TBL] [Abstract][Full Text] [Related]